Research Paper Volume 12, Issue 24 pp 25304—25318
Identification of novel prognostic biomarkers in renal cell carcinoma
Figure 7. DFS of the signature with multiple genes in RCC. (A) Patients were classified by risk score and their survival status; (B) DFS of the signature of multiple genes in this model, which indicated that patients in the low-risk group had a better DFS than those in the high-risk group. (C) ROC curves suggested that the accuracy of this model was 74.3%, 74.7% and 77.4% at 1, 3 and 5 years, respectively.